
|Articles|February 1, 2004
Isotretinoin, retinoids key evolution
Many of the modern therapies that evolved during the last 25 years are new, more patient-friendly twists on old therapies. Harsh treatments with unpleasant odors that fail to diminish the most severe forms of acne and rosacea are no longer the main tools in the dermatologists' arsenal.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
JAK Inhibitors Show Comparable Safety to TNF Antagonists
3
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
4
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 1
5


















